BIOMAT Database Logo BIOMAT Database Logo

Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. 1995

M Negrini, and D Rasio, and G M Hampton, and S Sabbioni, and S Rattan, and S L Carter, and A L Rosenberg, and G F Schwartz, and Y Shiloh, and W K Cavenee
Jefferson Cancer Institute, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA.

Chromosome 11 is frequently altered in several types of human neoplasms. In breast cancer, loss of heterozygosity has been described in two regions of this chromosome, 11p15 and 11q22-23. In this report we have dissected the two regions using high-density polymorphic markers, and have found that there are at least two independent areas of loss of heterozygosity in each region, suggesting that multiple genes on chromosome 11 may be targets of genetic alteration during tumor establishment or progression. The regions defined are: at 11p15, between loci D11S576 and D11S1318 and between D11S988 and D11S1318; at 11q23, between D11S2000 and D11S897 and between D11S528 and D11S990. The narrowing of these regions of loss should facilitate the cloning of the regions in yeast artificial chromosomes to identify the critical tumor suppressor genes.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008940 Mitotic Index An expression of the number of mitoses found in a stated number of cells. Index, Mitotic,Indices, Mitotic,Mitotic Indices
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D002880 Chromosomes, Human, Pair 11 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 11
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes

Related Publications

M Negrini, and D Rasio, and G M Hampton, and S Sabbioni, and S Rattan, and S L Carter, and A L Rosenberg, and G F Schwartz, and Y Shiloh, and W K Cavenee
Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis.
March 1996, Cancer research,
M Negrini, and D Rasio, and G M Hampton, and S Sabbioni, and S Rattan, and S L Carter, and A L Rosenberg, and G F Schwartz, and Y Shiloh, and W K Cavenee
Definition and refinement of chromosome 8p regions of loss of heterozygosity in gastric cancer.
April 2000, Clinical cancer research : an official journal of the American Association for Cancer Research,
M Negrini, and D Rasio, and G M Hampton, and S Sabbioni, and S Rattan, and S L Carter, and A L Rosenberg, and G F Schwartz, and Y Shiloh, and W K Cavenee
Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer.
February 1996, Cancer research,
M Negrini, and D Rasio, and G M Hampton, and S Sabbioni, and S Rattan, and S L Carter, and A L Rosenberg, and G F Schwartz, and Y Shiloh, and W K Cavenee
Definition of a region of loss of heterozygosity at chromosome 11q23.3-25 in head and neck squamous cell carcinoma using laser capture microdissection technique.
March 2004, Diagnostic molecular pathology : the American journal of surgical pathology, part B,
M Negrini, and D Rasio, and G M Hampton, and S Sabbioni, and S Rattan, and S L Carter, and A L Rosenberg, and G F Schwartz, and Y Shiloh, and W K Cavenee
Loss of heterozygosity on chromosome 11 q in breast cancer.
May 1995, Journal of clinical pathology,
M Negrini, and D Rasio, and G M Hampton, and S Sabbioni, and S Rattan, and S L Carter, and A L Rosenberg, and G F Schwartz, and Y Shiloh, and W K Cavenee
Definition of a region of loss of heterozygosity at chromosome 11q in cervical carcinoma.
June 1999, Diagnostic molecular pathology : the American journal of surgical pathology, part B,
M Negrini, and D Rasio, and G M Hampton, and S Sabbioni, and S Rattan, and S L Carter, and A L Rosenberg, and G F Schwartz, and Y Shiloh, and W K Cavenee
Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3.
September 1994, Cancer research,
M Negrini, and D Rasio, and G M Hampton, and S Sabbioni, and S Rattan, and S L Carter, and A L Rosenberg, and G F Schwartz, and Y Shiloh, and W K Cavenee
Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer.
April 1995, Cancer research,
M Negrini, and D Rasio, and G M Hampton, and S Sabbioni, and S Rattan, and S L Carter, and A L Rosenberg, and G F Schwartz, and Y Shiloh, and W K Cavenee
Loss of heterozygosity at chromosome 1p in human breast cancer.
October 1996, International journal of oncology,
M Negrini, and D Rasio, and G M Hampton, and S Sabbioni, and S Rattan, and S L Carter, and A L Rosenberg, and G F Schwartz, and Y Shiloh, and W K Cavenee
Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations.
September 1995, British journal of cancer,
Copied contents to your clipboard!